Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,409 | -9,568 | -30,146 | -20,748 | -13,310 |
| Depreciation Amortization | 94 | 164 | 182 | 138 | 89 |
| Accounts receivable | -248 | 512 | -212 | -120 | -367 |
| Accounts payable and accrued liabilities | -1,947 | -1,521 | 2,095 | 818 | 890 |
| Other Working Capital | -2,301 | -1,097 | 854 | -1,053 | 821 |
| Other Operating Activity | 3,614 | 1,861 | -314 | 397 | 171 |
| Operating Cash Flow | $-21,197 | $-9,649 | $-27,541 | $-20,568 | $-11,706 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | -45 | -74 | -33 |
| Other Investing Activity | 0 | 0 | 226 | 236 | 237 |
| Investing Cash Flow | $-3 | $N/A | $181 | $162 | $204 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,583 | 23,642 | 52,922 | 52,667 | 52,369 |
| Financing Cash Flow | $23,583 | $23,642 | $52,922 | $52,667 | $52,369 |
| Beginning Cash Position | 42,370 | 42,370 | 16,808 | 16,808 | 16,808 |
| End Cash Position | 44,753 | 56,363 | 42,370 | 49,069 | 57,675 |
| Net Cash Flow | $2,383 | $13,993 | $25,562 | $32,261 | $40,867 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,197 | -9,649 | -27,541 | -20,568 | -11,706 |
| Capital Expenditure | -3 | N/A | -45 | -74 | -33 |
| Free Cash Flow | -21,200 | -9,649 | -27,586 | -20,642 | -11,739 |